Quadrant Capital Group LLC Atri Cure, Inc. Transaction History

Quadrant Capital Group LLC

$1.43 Billion
Q4 2024

A detailed history of Quadrant Capital Group LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 275 shares of ATRC stock, worth $10,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275

Previous 275 -0.0%

Holding current value

$10,557

Previous $7,000 14.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$20.34 - $29.5 $1,200 - $1,740	-59 Reduced 17.66%	275 $7,000
Q2 2024 Aug 12, 2024	BUY	$19.86 - $29.09 $516 - $756	26 Added 8.44%	334 $7,000
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $5,106 - $6,838	-181 Reduced 37.01%	308 $9,000
Q4 2023 Feb 08, 2024	BUY	$32.99 - $43.25 $7,059 - $9,255	214 Added 77.82%	489 $17,000
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $411 - $577	-10 Reduced 3.51%	275 $12,000
Q2 2023 Aug 09, 2023	BUY	$40.44 - $49.6 $404 - $496	10 Added 3.64%	285 $14,000
Q1 2023 May 11, 2023	SELL	$35.87 - $47.22 $1,076 - $1,416	-30 Reduced 9.84%	275 $11,000
Q4 2022 Feb 10, 2023	SELL	$33.48 - $47.45 $8,236 - $11,672	-246 Reduced 44.65%	305 $13,000
Q3 2022 Nov 10, 2022	BUY	$38.25 - $52.62 $3,710 - $5,104	97 Added 21.37%	551 $22,000
Q2 2022 Aug 09, 2022	BUY	$35.1 - $66.01 $4,036 - $7,591	115 Added 33.92%	454 $19,000
Q4 2021 Feb 01, 2022	SELL	$63.4 - $87.14 $697 - $958	-11 Reduced 3.14%	339 $24,000
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $415 - $506	6 Added 1.74%	350 $24,000
Q2 2021 Aug 09, 2021	SELL	$64.13 - $80.18 $384 - $481	-6 Reduced 1.71%	344 $27,000
Q1 2021 May 12, 2021	BUY	$53.79 - $66.98 $215 - $267	4 Added 1.16%	350 $23,000
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $2,522 - $4,201	-73 Reduced 17.42%	346 $19,000
Q3 2020 Nov 13, 2020	SELL	$38.36 - $46.91 $843 - $1,032	-22 Reduced 4.99%	419 $17,000
Q2 2020 Aug 13, 2020	BUY	$31.78 - $51.19 $476 - $767	15 Added 3.52%	441 $20,000
Q1 2020 May 15, 2020	SELL	$24.49 - $43.84 $465 - $832	-19 Reduced 4.27%	426 $14,000
Q4 2019 Feb 03, 2020	BUY	$24.06 - $32.51 $10,706 - $14,466	445 New	445 $14,000

Others Institutions Holding ATRC

# of Institutions

229

Shares Held

47.1M

Call Options Held

25.8K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.78B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Atri Cure, Inc. Transaction History